{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:28:38Z","timestamp":1794083318415,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1245\/s10434-011-2168-3","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T15:39:59Z","timestamp":1323790799000},"page":"1928-1935","source":"Crossref","is-referenced-by-count":114,"title":["Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment"],"prefix":"10.1245","volume":"19","author":[{"given":"George A.","family":"Poultsides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyen C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph H.","family":"Hruban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barish H.","family":"Edil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Choti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"2168_CR1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00000658-199806000-00005","volume":"227","author":"CJ Yeo","year":"1998","unstructured":"Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227:821\u201331.","journal-title":"Ann Surg."},{"key":"2168_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20\u00a0years. Ann Surg. 2009;249:63\u201371.","journal-title":"Ann Surg."},{"key":"2168_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin."},{"key":"2168_CR4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1245\/s10434-007-9428-2","volume":"14","author":"S Agrawal","year":"2007","unstructured":"Agrawal S, McCarron EC, Gibbs JF, et al. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol. 2007;14:2263\u20139.","journal-title":"Ann Surg Oncol."},{"key":"2168_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archsurg.142.3.229","volume":"142","author":"I Hatzaras","year":"2007","unstructured":"Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. Arch Surg. 2007;142:229\u201335.","journal-title":"Arch Surg."},{"key":"2168_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9610(84)90036-9","volume":"147","author":"K Ouriel","year":"1984","unstructured":"Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg. 1984;147:66\u201371.","journal-title":"Am J Surg."},{"key":"2168_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02303544","volume":"1","author":"G Barnes","year":"1994","unstructured":"Barnes G, Romero L, Hess KR, et al. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol. 1994;1:73\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2168_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9610(99)00269-X","volume":"179","author":"IG Kaklamanos","year":"2000","unstructured":"Kaklamanos IG, Bathe OF, Franceschi D, et al. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000;179:37\u201341.","journal-title":"Am J Surg."},{"key":"2168_CR9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/archsurg.135.9.1070","volume":"135","author":"NM Ryder","year":"2000","unstructured":"Ryder NM, Ko CY, Hines OJ, et al. Primary duodenal adenocarcinoma: a 40-year experience. Arch Surg. 2000;135:1070\u20134.","journal-title":"Arch Surg."},{"key":"2168_CR10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1245\/ASO.2004.05.021","volume":"11","author":"AI Sarela","year":"2004","unstructured":"Sarela AI, Brennan MF, Karpeh MS, et al. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol. 2004;11:380\u20136.","journal-title":"Ann Surg Oncol."},{"key":"2168_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00000658-198001000-00003","volume":"191","author":"A Alwmark","year":"1980","unstructured":"Alwmark A, Andersson A, Lasson A. Primary carcinoma of the duodenum. Ann Surg. 1980;191:13\u20138.","journal-title":"Ann Surg."},{"key":"2168_CR12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archsurg.1992.01420050081010","volume":"127","author":"JA Lowell","year":"1992","unstructured":"Lowell JA, Rossi RL, Munson JL, et al. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. Arch Surg. 1992;127:557\u201360.","journal-title":"Favorable prognosis after resection. Arch Surg."},{"key":"2168_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0002-9610(05)80668-3","volume":"166","author":"R Delcore","year":"1993","unstructured":"Delcore R, Thomas JH, Forster J, et al. Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg. 1993;166:626\u201330.","journal-title":"Am J Surg."},{"key":"2168_CR14","first-page":"83","volume":"81","author":"N Rotman","year":"1994","unstructured":"Rotman N, Pezet D, Fagniez PL, et al. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research. Br J Surg. 1994;81:83\u20135.","journal-title":"French Association for Surgical Research. Br J Surg."},{"key":"2168_CR15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archsurg.135.6.635","volume":"135","author":"FG Bakaeen","year":"2000","unstructured":"Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000;135:635\u201341.","journal-title":"Arch Surg."},{"key":"2168_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.amjsurg.2006.09.013","volume":"193","author":"MG Hurtuk","year":"2007","unstructured":"Hurtuk MG, Devata S, Brown KM, et al. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? Am J Surg. 2007;193:319\u201324.","journal-title":"Am J Surg."},{"key":"2168_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12029-009-9073-z","volume":"40","author":"SL Han","year":"2009","unstructured":"Han SL, Cheng J, Zhou HZ, et al. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer. 2009;40:33\u201337.","journal-title":"J Gastrointest Cancer."},{"key":"2168_CR18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jso.21319","volume":"100","author":"A Struck","year":"2009","unstructured":"Struck A, Howard T, Chiorean EG, et al. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009;100:144\u20138.","journal-title":"J Surg Oncol."},{"key":"2168_CR19","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s00268-008-9678-6","volume":"32","author":"HG Lee","year":"2008","unstructured":"Lee HG, You DD, Paik KY, et al. Prognostic factors for primary duodenal adenocarcinoma. World J Surg. 2008;32:2246\u201352.","journal-title":"World J Surg."},{"key":"2168_CR20","first-page":"251","volume":"77","author":"RB Sexe","year":"1996","unstructured":"Sexe RB, Wade TP, Virgo KS, et al. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer. 1996;77:251\u20134.","journal-title":"Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer."},{"key":"2168_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1091-255X(98)80107-8","volume":"2","author":"TA Sohn","year":"1998","unstructured":"Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998;2:79\u201387.","journal-title":"J Gastrointest Surg."},{"key":"2168_CR22","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2007.05.006","volume":"69","author":"CR Kelsey","year":"2007","unstructured":"Kelsey CR, Nelson JW, Willett CG, et al. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:1436\u201341.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2168_CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11605-009-1080-7","volume":"14","author":"JM Winter","year":"2010","unstructured":"Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg. 2010;14:379\u201387.","journal-title":"J Gastrointest Surg."},{"key":"2168_CR24","unstructured":"R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing Development Core Team, 2007."},{"key":"2168_CR25","volume-title":"American Joint Committee on Cancer (AJCC) staging manual 7th edn","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC) staging manual. 7th ed. New York: Springer-Verlag, 2010."},{"key":"2168_CR26","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1245\/s10434-010-1109-x","volume":"17","author":"MB Nicholl","year":"2010","unstructured":"Nicholl MB, Ahuja V, Conway WC, et al. Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol. 2010;17:2728\u201332.","journal-title":"Ann Surg Oncol."},{"key":"2168_CR27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1245\/ASO.2004.02.914","volume":"11","author":"JF Gibbs","year":"2004","unstructured":"Gibbs JF. Duodenal adenocarcinoma: is total lymph node sampling predictive of outcome? Ann Surg Oncol. 2004;11:354\u20135.","journal-title":"Ann Surg Oncol."},{"key":"2168_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.4881","volume":"92","author":"CA Seiler","year":"2005","unstructured":"Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection\u2014long term results. Br J Surg. 2005;92:547\u201356.","journal-title":"Br J Surg."},{"key":"2168_CR29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.sla.0000143248.71964.29","volume":"240","author":"KT Tran","year":"2004","unstructured":"Tran KT, Smeenk HG, van Eijck CH, et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg. 2004;240:738\u201345.","journal-title":"Ann Surg."},{"key":"2168_CR30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-200209000-00012","volume":"236","author":"CJ Yeo","year":"2002","unstructured":"Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355\u201366.","journal-title":"Ann Surg."},{"key":"2168_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archsurg.142.3.285","volume":"142","author":"MJ Swartz","year":"2007","unstructured":"Swartz MJ, Hughes MA, Frassica DA, et al. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007;142:285\u20138.","journal-title":"Arch Surg."},{"key":"2168_CR32","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/cncr.23822","volume":"113","author":"MJ Overman","year":"2008","unstructured":"Overman MJ, Kopetz S, Wen S, et al. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008;113:2038\u201345.","journal-title":"Cancer."},{"key":"2168_CR33","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","volume":"27","author":"MJ Overman","year":"2009","unstructured":"Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598\u2013603.","journal-title":"J Clin Oncol."},{"key":"2168_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","volume":"10","author":"MK Gibson","year":"2005","unstructured":"Gibson MK, Holcroft CA, Kvols LK, et al. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma. Oncologist. 2005;10:132\u20137.","journal-title":"Oncologist."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-2168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-2168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-2168-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:45:53Z","timestamp":1572972353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-2168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-2168-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}